We are live on ! Find out more
IRMD icon

iRadimed

61 hedge funds and large institutions have $140M invested in iRadimed in 2021 Q2 according to their latest regulatory filings, with 11 funds opening new positions, 17 increasing their positions, 24 reducing their positions, and 4 closing their positions.

New
Increased
Maintained
Reduced
Closed

175% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 4

15% more capital invested

Capital invested by funds: $122M → $140M (+$18.2M)

13% more funds holding

Funds holding: 5461 (+7)

0.36% more ownership

Funds ownership: 38.42%38.78% (+0.36%)

29% less repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 24

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
61
Holders Change
+7
Holders Change %
+12.96%
% of All Funds
1.06%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
11
Increased
17
Reduced
24
Closed
4
Calls
Puts
Net Calls
Net Calls Change

IRMD Hedge Fund Activity: Q2 2021 in Review

61 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in iRadimed (IRMD) for Q2 2021, worth a combined $140M — up 15% from $122M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new IRMD positions and 4 closed out — a net gain of 7 holders — while 17 added to existing stakes and 24 trimmed.

The largest buyer was Vanguard Group, adding an estimated $5.18M. The largest seller was Russell Investments Group, cutting an estimated $2.87M.

  • 61 institutional investors held iRadimed (IRMD) as of Q2 2021, up from 54 in Q1 2021.
  • Funds reported $140M of iRadimed stock for Q2 2021, up 15% quarter-over-quarter.
  • 11 funds opened new iRadimed positions in Q2 2021 and 4 closed out, a net change of +7 holders.
  • The largest iRadimed buyer in Q2 2021 was Vanguard Group, an estimated $5.18M added.
  • The largest iRadimed seller in Q2 2021 was Russell Investments Group, an estimated $2.87M sold.

Based on aggregated 13F filings for Q2 2021.